Este site utiliza cookies para otimizar o seu funcionamento. Ao utilizar este site, concorda com a colocação de cookies no seu dispositivo.
O uso e acesso a este serviço encontra-se sujeito à Política de Privacidade.

Fechar
Roche Navigation Menu RocheNet : RocheNet
  • Contactos
  • Entrar
  • Logout
  • Pesquisa
Roche
  • Topo
  • Homepage
  • Search
  • Close search

						
							

Searching

    • Homepage
    • MedInfo
      MedInfo
      • Pedido de Informação sobre Medicamentos Roche
      • Contactos MedInfo
      Em destaque

      Pedido de Informação sobre Medicamentos

    • Medicamentos
      Medicamentos
      • Pedido de Informação sobre Medicamentos Roche
      • Bases de Dados de Medicamentos
      • Infomed
      • Prontuário Terapêutico
      • Simposium Terapêutico
      Em destaque

      Medicamentos Roche

    • Especialidades
      Especialidades
      • Dermatologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Hematologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Oncologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Hemofilia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Pneumologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Neurologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      • Reumatologia
      • Eventos
      • Guidelines
      • Revistas
      • Sites
      Em destaque

      Hematologia

    • Publicações e Bases de Dados
      Publicações e Bases de Dados
      • Bases de Dados
      • PubMed
      • Revistas Free Full Text
      • Bibliotecas Nacionais
      • Medicamentos
      • Infomed
      • Prontuário Terapêutico
      • Simposium Terapêutico
      • Guidelines
      • Dermatologia
      • Hematologia
      • Neurologia
      • Oncologia
      • Pneumologia
      • Reumatologia
      Em destaque

      Revistas Free Full Text

    • Sites e e-Learning
      Sites e e-Learning
      • Sites e Apps Roche
      • Artrite Reumatóide
      • Emagreça com Saúde
      • Hepatites
      • Her2+
      • Imunoterapia
      • InfoCancro
      • Linfoma
      • Site PHC
      • Sites Nacionais
      • Associações Profissionais
      • Associações de Doentes
      • Hospitais e Serviços Hospitalares
      • Instituições
      • Portais e outros sites saúde
      • Publicações
      • Serviços Saúde
      • Sociedades e Ordens
      • Universidades e Ensino
      • Sites por Especialidade
      • Dermatologia
      • Hematologia
      • Neurologia
      • Oncologia
      • Pneumologia
      • Reumatologia
      • Education & e-Learning
      • ASCO
      • Bio Academy
      • ECCO
      • SABC
      • Imunoterapia contra o cancro
      Em destaque

      Sites Roche

    • Agenda de Eventos
      Agenda de Eventos
      • Eventos de 2019
      • Eventos de 2018
      • Sugerir Eventos
      • Dermatologia
      • Hematologia
      • Hemofilia
      • Oncologia
      • Pneumologia
      • Reumatologia
      • Neurologia
      • Eventos Roche
      • ASH Review 2019
      • Inspired 2019
      • SHE 2019
      • PHC 2019
      Em destaque

      Próximos Eventos

    Fechar

    1 - of Resultado(s) para ""

    No results

    • Site PHC
    • Personalised Healthcare
      • About PHC
      • Definition
      • Targeted Therapy
      • Healthcare Impact
      • Pubmed Free Full Text Articles
      • Pubmed Articles
    • Biomarcadores
    • Patologias
      • Breast Cancer
      • Lung Cancer
      • Lymphomas
      • Gastric Cancer
      • Melanoma
      • Basal Cell Carcinoma
      • Colorectal Cancer
    • Guidelines
    • Publicações
    • Sites
    • Eventos
    • Mais
      • Personalised Healthcare
      • Biomarcadores
      • Patologias
      • Guidelines
      • Publicações
      • Sites
      • Eventos

    Está aqui

    1. Sites e e-Learning
    2. Site PHC
    3. Patologias
    4. Basal Cell Carcinoma
    5. Approach Techniques

    Approach Techniques

    The goal of treatment for BCC is complete removal of the tumour, in a manner likely to result in a cosmetic outcome that is acceptable to the patient.1

    Surgical modalities are the most common and effective treatment for most primary BCCs.2 The type of surgical procedure used is dependent on the characteristics of the tumour.3 Mohs micrographic surgery – a microscopically controlled technique that affords precise margin control – is associated with an extremely high cure rate (five-year cure rate using Mohs surgery is estimated at 99% for primary BCCs, and up to 95% for recurrent BCCs).4 Curettage and electrodessication/cautery, or cryosurgery, can each achieve five-year cure rates of 95% or more but are best reserved for low-risk lesions that are small, well defined and in a non-critical site.4-6

    Tumours that are not appropriate for surgery, or for which surgery would result in substantial deformity (such as difficult to treat locations) may require treatment with non-surgical approaches. Radiotherapy is a useful treatment for some inoperable or unresectable basal cell carcinoma lesions, in patients who cannot tolerate surgery and for elderly patients.4 It is less suitable for younger patients and for large tumours in critical sites,6 and is contraindicated in genetic syndromes predisposing to skin cancer, such as Gorlin syndrome.1 Photodynamic therapy or topical creams can be effective for certain superficial BCCs and generally provide good cosmetic outcomes.7-9 However, each of these treatments is generally less effective for the most common type of BCC, nodular BCCs.6,10

    Advanced BCC

    Types of BCC

    Risk factors

    References:

    1. Telfer NR, et al. Guidelines for the management of basal cell carcinoma. Brit J Dermatol. 2008; 159(1):35-48.

    2. Epstein EH. Basal cell carcinomas: attack of the hedgehog. Nat Rev Cancer. 2008;8:743-754.

    3. Samarasinghe V. Focus on basal cell carcinoma. J Skin Cancer. 2011;328615.

    4. Wong B, et al. Basal Cell Carcinoma. BMJ. 2003;327:794-798.

    5. Zacarian SA. Cryosurgery of cutaneous carcinomas. J Am Acad Dermatol. 1983;9(6):947-956.

    6. Sterry W. Guidelines: The management of basal cell carcinoma. Eur J Dermatol. 2006;16(5):467-475.

    7. Gollnick H, et al. Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe. Eur J Dermatol. 2008;18(6):677-682.

    8. Gross K, et al. 5% 5-Fluorouracil Cream for the Treatment of Small Superficial Basal Cell Carcinoma: Efficacy, Tolerability, Cosmetic Outcome, and Patient Satisfaction. Dermatol Surg. 2007;33:433-440.

    9. Rhodes LE, et al. Five-Year Follow-up of a Randomized, Prospective Trial of Topical Methyl Aminolevulinate Photodynamic Therapy vs Surgery for Nodular Basal Cell Carcinoma. Arch Dermatol. 2007;143(9):1131-1136.10. Alessi SS, et al. Treatment of cutaneous tumors with topical 5% imiquimod cream. Clinics. 2009;64(10):961-966.

    Partilhar
    • Partilhar via email
    • Partilhar via Facebook
    • Partilhar via Twitter
    • Partilhar via Linkedin
    • Partilhar via Google+
    Fechar

    "Roche"

    RocheNet

    A sua sessão na RocheNet vai expirar. Quer continuar?

    SIM NÃO
    • © 2019 Roche Portugal
    • 29.01.2019
    • Termos Legais
    • Política de Privacidade

    • Encontre-nos no Twitter
    • Encontre-nos no Linkedin
    • Encontre-nos no Facebook
    • Encontre-nos no Youtube
    • Encontre-nos no Pinterest